Immediate prediction of post-ERCP pancreatitis: a novel approach using serum trypsin - Takeaways - MDSpire

Immediate prediction of post-ERCP pancreatitis: a novel approach using serum trypsin

  • By

  • Takashi Tamura

  • Seiji Fujigaki

  • Tsuyoshi Sanuki

  • Tetsuya Ikeda

  • Satoshi Sugimori

  • Tsukasa Ikeura

  • Shinji Nakayama

  • Tomoya Emori

  • Kazuhiro Fukatsu

  • Yasutaka Ishii

  • Shiro Oka

  • Kenji Ikezawa

  • Ryoji Takada

  • Masanori Asada

  • Ayana Kishibuchi

  • Takeshi Ogura

  • Nobu Nishioka

  • Masaaki Shimatani

  • Masataka Kano

  • Arata Sakai

  • Kae Nagao

  • Shuhei Shintani

  • Osamu Inatomi

  • Masayuki Kitano

  • July 7, 2026

  • 0 min

Share

  • 1

    Post-ERCP pancreatitis (PEP) occurs in approximately 5–15% of ERCP cases and can be severe, requiring intensive care.

  • 2

    Serum amylase (AMY) levels are commonly used to predict PEP, with levels exceeding twice the upper limit of normal indicating high incidence.

  • 3

    Measuring serum trypsin (TRY) levels may allow for earlier detection of PEP compared to AMY or lipase levels.

  • 4

    This study involved a multicenter observational design across 12 hospitals in Japan to assess TRY as a predictive marker for PEP.

  • 5

    Patients were included if they were ≥ 20 years old with an intact papilla and excluded if they had acute pancreatitis or were on dialysis.

Original Source(s)

Related Content